Concepedia

Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients

Li Wang, Michele C. Madigan, Hongmin Chen, Fenghua Liu, Kate Patterson, Julia Beretov, Philippa M. O’Brien, Yong Li

Gynecologic Oncology · 2009 · 48 citations · 28 references

DOI

Concepts

References

28

Marimastat as First-Line Therapy for Patients With Unresectable Pancreatic Cancer: A Randomized Trial

Simon R. Bramhall, Alexander S. Rosemurgy, Peter de Nully Brown et al. · Journal of Clinical Oncology · 2001 · 434 citations

, , +11

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.

John A. Foekens, Harry A. Peters, Maxime P. Look et al. · PubMed · 2000 · 429 citations · Full text

, , +15

A Role for Caveolin and the Urokinase Receptor in Integrin-mediated Adhesion and Signaling

Ying Wei, Xiuwei H. Yang, Qiumei Liu et al. · The Journal of Cell Biology · 1999 · 392 citations · Full text

, , +16

Clinical Impact of the Plasminogen Activation System in Tumor Invasion and Metastasis: Prognostic Relevance and Target for Therapy

Manfred Schmitt, Nadia Harbeck, Christoph Thomssen et al. · Thrombosis and Haemostasis · 1997 · 387 citations

, , +17

Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.

Barbara Schmalfeldt, Dieter Prechtel, Kathrin Härting et al. · PubMed · 2001 · 336 citations

, , +16